Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib

NCT05184595 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

OTHER: Carfilzomib delivered in OH only
OTHER: Carfilzomib delivered in OH and HaH combined

Sponsor

Central Hospital, Nancy, France